1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Microbiome Therapies Market Size 2016-2026 2.1.2 Microbiome Therapies Market Size CAGR by Region 2020 VS 2021 VS 2026 2.2 Microbiome Therapies Segment by Microbes 2.2.1 Bacteria 2.2.2 Bacteria 2.2.3 Virus 2.2.4 Others 2.3 Microbiome Therapies Market Size by Microbes 2.3.1 Global Microbiome Therapies Market Size CAGR by Microbes 2.3.2 Global Microbiome Therapies Market Size Market Share by Microbes (2016-2021) 2.4 Microbiome Therapies Segment by End User 2.4.1 Testing Centres 2.4.2 Research Labs 2.4.3 Horticulture 2.4.4 Others 2.5 Microbiome Therapies Market Size by End User 2.5.1 Global Microbiome Therapies Market Size CAGR by End User 2.5.2 Global Microbiome Therapies Market Size Market Share by End User (2016-2021) 3 Microbiome Therapies Market Size by Players 3.1 Microbiome Therapies Market Size Market Share by Players 3.1.1 Global Microbiome Therapies Revenue by Players (2019-2021E) 3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2019-2021E) 3.2 Global Microbiome Therapies Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Microbiome Therapies by Regions 4.1 Microbiome Therapies Market Size by Regions (2016-2021) 4.2 Americas Microbiome Therapies Market Size Growth (2016-2021) 4.3 APAC Microbiome Therapies Market Size Growth (2016-2021) 4.4 Europe Microbiome Therapies Market Size Growth (2016-2021) 4.5 Middle East & Africa Microbiome Therapies Market Size Growth (2016-2021) 5 Americas 5.1 Americas Microbiome Therapies Market Size by Country (2016-2021) 5.2 Americas Microbiome Therapies Market Size by Microbes (2016-2021) 5.3 Americas Microbiome Therapies Market Size by End User (2016-2021) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Microbiome Therapies Market Size by Region (2016-2021) 6.2 APAC Microbiome Therapies Market Size by Microbes (2016-2021) 6.3 APAC Microbiome Therapies Market Size by End User (2016-2021) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Microbiome Therapies by Country (2016-2021) 7.2 Europe Microbiome Therapies Market Size by Microbes (2016-2021) 7.3 Europe Microbiome Therapies Market Size by End User (2016-2021) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Microbiome Therapies by Region (2016-2021) 8.2 Middle East & Africa Microbiome Therapies Market Size by Microbes (2016-2021) 8.3 Middle East & Africa Microbiome Therapies Market Size by End User (2016-2021) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Global Microbiome Therapies Market Forecast 10.1 Global Microbiome Therapies Forecast by Regions (2021-2026) 10.1.1 Global Microbiome Therapies Forecast by Regions (2021-2026) 10.1.2 Americas Microbiome Therapies Forecast 10.1.3 APAC Microbiome Therapies Forecast 10.1.4 Europe Microbiome Therapies Forecast 10.1.5 Middle East & Africa Microbiome Therapies Forecast 10.2 Americas Microbiome Therapies Forecast by Countries (2021-2026) 10.2.1 United States Microbiome Therapies Market Forecast 10.2.2 Canada Microbiome Therapies Market Forecast 10.2.3 Mexico Microbiome Therapies Market Forecast 10.2.4 Brazil Microbiome Therapies Market Forecast 10.3 APAC Microbiome Therapies Forecast by Region (2021-2026) 10.3.1 China Microbiome Therapies Market Forecast 10.3.2 Japan Microbiome Therapies Market Forecast 10.3.3 Korea Microbiome Therapies Market Forecast 10.3.4 Southeast Asia Microbiome Therapies Market Forecast 10.3.5 India Microbiome Therapies Market Forecast 10.3.6 Australia Microbiome Therapies Market Forecast 10.4 Europe Microbiome Therapies Forecast by Country (2021-2026) 10.4.1 Germany Microbiome Therapies Market Forecast 10.4.2 France Microbiome Therapies Market Forecast 10.4.3 UK Microbiome Therapies Market Forecast 10.4.4 Italy Microbiome Therapies Market Forecast 10.4.5 Russia Microbiome Therapies Market Forecast 10.5 Middle East & Africa Microbiome Therapies Forecast by Region (2021-2026) 10.5.1 Egypt Microbiome Therapies Market Forecast 10.5.2 South Africa Microbiome Therapies Market Forecast 10.5.3 Israel Microbiome Therapies Market Forecast 10.5.4 Turkey Microbiome Therapies Market Forecast 10.5.5 GCC Countries Microbiome Therapies Market Forecast 10.6 Global Microbiome Therapies Forecast by Microbes (2021-2026) 10.8 Global Microbiome Therapies Forecast by End User (2021-2026) 11 Key Players Analysis 11.1 uBiome 11.1.1 uBiome Company Information 11.1.2 uBiome Microbiome Therapies Product Offered 11.1.3 uBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.1.4 uBiome Main Business Overview 11.1.5 uBiome Latest Developments 11.2 Evolve BioSystems 11.2.1 Evolve BioSystems Company Information 11.2.2 Evolve BioSystems Microbiome Therapies Product Offered 11.2.3 Evolve BioSystems Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.2.4 Evolve BioSystems Main Business Overview 11.2.5 Evolve BioSystems Latest Developments 11.3 Indigo Agriculture 11.3.1 Indigo Agriculture Company Information 11.3.2 Indigo Agriculture Microbiome Therapies Product Offered 11.3.3 Indigo Agriculture Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.3.4 Indigo Agriculture Main Business Overview 11.3.5 Indigo Agriculture Latest Developments 11.4 Pivot Bio 11.4.1 Pivot Bio Company Information 11.4.2 Pivot Bio Microbiome Therapies Product Offered 11.4.3 Pivot Bio Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.4.4 Pivot Bio Main Business Overview 11.4.5 Pivot Bio Latest Developments 11.5 Concentric Ag 11.5.1 Concentric Ag Company Information 11.5.2 Concentric Ag Microbiome Therapies Product Offered 11.5.3 Concentric Ag Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.5.4 Concentric Ag Main Business Overview 11.5.5 Concentric Ag Latest Developments 11.6 Epibiome 11.6.1 Epibiome Company Information 11.6.2 Epibiome Microbiome Therapies Product Offered 11.6.3 Epibiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.6.4 Epibiome Main Business Overview 11.6.5 Epibiome Latest Developments 11.7 CosmosID 11.7.1 CosmosID Company Information 11.7.2 CosmosID Microbiome Therapies Product Offered 11.7.3 CosmosID Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.7.4 CosmosID Main Business Overview 11.7.5 CosmosID Latest Developments 11.8 Human Longevity 11.8.1 Human Longevity Company Information 11.8.2 Human Longevity Microbiome Therapies Product Offered 11.8.3 Human Longevity Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.8.4 Human Longevity Main Business Overview 11.8.5 Human Longevity Latest Developments 11.9 Ajinomoto Cambrooke 11.9.1 Ajinomoto Cambrooke Company Information 11.9.2 Ajinomoto Cambrooke Microbiome Therapies Product Offered 11.9.3 Ajinomoto Cambrooke Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.9.4 Ajinomoto Cambrooke Main Business Overview 11.9.5 Ajinomoto Cambrooke Latest Developments 11.10 AnimalBiome 11.10.1 AnimalBiome Company Information 11.10.2 AnimalBiome Microbiome Therapies Product Offered 11.10.3 AnimalBiome Microbiome Therapies Revenue, Gross Margin and Market Share (2019-2021) 11.10.4 AnimalBiome Main Business Overview 11.10.5 AnimalBiome Latest Developments 12 Research Findings and Conclusion
According to this latest study, the 2021 growth of Microbiome Therapies will have significant change from previous year. By the most conservative estimates of global Microbiome Therapies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Microbiome Therapies market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
Segmentation by microbes: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Bacteria
Fungi
Virus
Others
Segmentation by end user: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Testing Centres
Research Labs
Horticulture
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
uBiome
Evolve BioSystems
Indigo Agriculture
Pivot Bio
Concentric Ag
Epibiome
CosmosID
Human Longevity
Ajinomoto Cambrooke
AnimalBiome
Summary:
Last updated on 08 February, 2021
Global Microbiome Therapies Market Growth (Status and Outlook) 2021-2026
